A Polish Acute Leukemia Group Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016)
Agnieszka Wierzbowska(Medical University of Lodz), Gail J. Roboz(Cornell University), Agnieszka Pluta, Karol Wójcik, Anna Kopińska(Medical University of Silesia), Anna Czyż(Wroclaw Medical University), Alicja Sadowska‐Klasa(Jagiellonian University), Janusz Hałka(Wojskowy Instytut Medycyny Lotniczej), Tomasz Wróbel, Magdalena Czemerska(Medical University of Lodz), Marek Hus(Medical University of Lublin), Krzysztof Woźniczka(Medical University of Silesia), Marta Sobas, Agata Obara(Holy Cross University), Katarzyna Dulik(The Maria Sklodowska-Curie National Research Institute of Oncology), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Beata Blajer‐Olszewska, Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Lidia Gil(Poznan University of Medical Sciences), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Nicole M. Cruz(NewYork–Presbyterian Hospital), Małgorzata Raźny, Andrzej Szczepaniak(Poznan University of Medical Sciences), Tomasz Gromek(Medical University of Lublin), Pinkal Desai(NewYork–Presbyterian Hospital), Jolanta Woźniak(Instytut Hematologii i Transfuzjologi), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Jerzy Hołowiecki(Medical University of Silesia), Tadeusz Robak(Medical University of Lodz), Michał Soin(University of Łódź), Sang‐Min Lee(Seoul National University), Piotr Stelmach(Medical University of Lodz), Marta Libura(Medical University of Warsaw), Michael Samuel(NewYork–Presbyterian Hospital), Jan Maciej Zaucha(Gdańsk Medical University)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k